David Penson
Faculty Member
Last active: 2/23/2016

  1. Sensitivity of Medicare Claims to Identify Cancer Recurrence in Elderly Colorectal and Breast Cancer Patients. Warren JL, Mariotto A, Melbert D, Schrag D, Doria-Rose P, Penson D, Yabroff KR (2016) Med Care 54(8): e47-54
    › Primary publication · 24374419 (PubMed) · PMC4072852 (PubMed Central)
  2. Prostate Cancer, Version 1.2016. Mohler JL, Armstrong AJ, Bahnson RR, D'Amico AV, Davis BJ, Eastham JA, Enke CA, Farrington TA, Higano CS, Horwitz EM, Hurwitz M, Kane CJ, Kawachi MH, Kuettel M, Lee RJ, Meeks JJ, Penson DF, Plimack ER, Pow-Sang JM, Raben D, Richey S, Roach M, Rosenfeld S, Schaeffer E, Skolarus TA, Small EJ, Sonpavde G, Srinivas S, Strope SA, Tward J, Shead DA, Freedman-Cass DA (2016) J Natl Compr Canc Netw 14(1): 19-30
    › Primary publication · 26733552 (PubMed)
  3. Enzalutamide Versus Bicalutamide in Castration-Resistant Prostate Cancer: The STRIVE Trial. Penson DF, Armstrong AJ, Concepcion R, Agarwal N, Olsson C, Karsh L, Dunshee C, Wang F, Wu K, Krivoshik A, Phung D, Higano CS (2016) J Clin Oncol 34(18): 2098-106
    › Primary publication · 26811535 (PubMed)
  4. Doing More for More: Unintended Consequences of Financial Incentives for Oncology Specialty Care. O'Neil B, Graves AJ, Barocas DA, Chang SS, Penson DF, Resnick MJ (2016) J Natl Cancer Inst 108(2)
    › Primary publication · 26582063 (PubMed) · PMC6061232 (PubMed Central)
  5. Cardiovascular Effects of Androgen Deprivation Therapy for the Treatment of Prostate Cancer: ABCDE Steps to Reduce Cardiovascular Disease in Patients With Prostate Cancer. Bhatia N, Santos M, Jones LW, Beckman JA, Penson DF, Morgans AK, Moslehi J (2016) Circulation 133(5): 537-41
    › Primary publication · 26831435 (PubMed) · PMC5029929 (PubMed Central)
  6. Cardiology Patient Page. ABCDE Steps for Heart and Vascular Wellness Following a Prostate Cancer Diagnosis. Guan J, Khambhati J, Jones LW, Morgans A, Allaf M, Penson DF, Moslehi J (2015) Circulation 132(18): e218-20
    › Primary publication · 26527696 (PubMed) · PMC5004633 (PubMed Central)
  7. A 22 Gene-expression Assay, Decipher® (GenomeDx Biosciences) to Predict Five-year Risk of Metastatic Prostate Cancer in Men Treated with Radical Prostatectomy. Marrone M, Potosky AL, Penson D, Freedman AN (2015) PLoS Curr
    › Primary publication · 26664778 (PubMed) · PMC4659515 (PubMed Central)
  8. Variation in the intensity of hematuria evaluation: a target for primary care quality improvement. Friedlander DF, Resnick MJ, You C, Bassett J, Yarlagadda V, Penson DF, Barocas DA (2014) Am J Med 127(7): 633-640.e11
    › Primary publication · 24486290 (PubMed) · PMC4074456 (PubMed Central)
  9. Urinary functional outcomes in female neobladder patients. Bartsch G, Daneshmand S, Skinner EC, Syan S, Skinner DG, Penson DF (2014) World J Urol 32(1): 221-8
    › Primary publication · 24317553 (PubMed)
  10. The more, the merrier: including a medical oncologist in treatment planning for localized prostate cancer. Morgans AK, Penson DF (2014) J Oncol Pract 10(2): 113-4
    › Primary publication · 24399852 (PubMed)